Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Aljitawi OS"'
Publikováno v:
Journal of Blood Medicine, Vol 2014, Iss default, Pp 37-41 (2014)
Rahul D Pawar,1 Travis Williams,2 Rahul Khera,2 Albert Eid,3 Omar S Aljitawi,1,4 Reginald W Dusing5 1Internal Medicine, 2Hematology/Oncology, 3Infectious Diseases, 4Pathology and Laboratory Medicine, 5Radiology, University of Kansas Medical Center, K
Externí odkaz:
https://doaj.org/article/de6b6017353e4334925561afe35cc428
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Manogna D; Department of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA, USA. Electronic address: dmanogna@tulane.edu., Lipof JJ; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester, New York, USA. Electronic address: jodi_lipof@urmc.rochester.edu., Baran AM; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester, New York, USA. Electronic address: andrea_baran@urmc.rochester.edu., Said B; Department of Hematology and Oncology, Stony Brook University, Long Island, New York, USA. Electronic address: bassil.said@stonybrookmedicine.edu., Becker MW; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester, New York, USA. Electronic address: michael_becker@urmc.rochester.edu., Mendler JH; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester, New York, USA. Electronic address: jason_mendler@urmc.rochester.edu., Aljitawi OS; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester, New York, USA. Electronic address: omar_aljitawi@urmc.rochester.edu., O'Dwyer KM; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester, New York, USA. Electronic address: kristen_odwyer@urmc.rochester.edu., Huselton E; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester, New York, USA. Electronic address: eric_huselton@urmc.rochester.edu., Burack R; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester, New York, USA. Electronic address: richard_burack@urmc.rochester.edu., Blaney M; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester, New York, USA. Electronic address: margaret_blaney@urmc.rochester.edu., Liesveld JL; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester, New York, USA. Electronic address: jane_liesveld@urmc.rochester.edu., Loh KP; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester, New York, USA. Electronic address: kahpoh_loh@urmc.rochester.edu.
Publikováno v:
Journal of geriatric oncology [J Geriatr Oncol] 2023 Jan; Vol. 14 (1), pp. 101403. Date of Electronic Publication: 2022 Nov 10.
Autor:
Al-Kaabneh B; Hematology/Oncology Division, University of Rochester Medical Center, Rochester, NY 14642, USA., Frisch B; Departments of Pathology and Biomedical Engineering, University of Rochester Medical Center, Rochester, NY 14642, USA., Aljitawi OS; Hematology/Oncology Division, University of Rochester Medical Center, Rochester, NY 14642, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Oct 26; Vol. 14 (21). Date of Electronic Publication: 2022 Oct 26.
Autor:
LoCastro M; School of Medicine and Dentistry, University of Rochester, Rochester, NY., Baran AM; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute., Liesveld JL; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute., Huselton E; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute., Becker MW; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute., O'Dwyer KM; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute., Aljitawi OS; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute., Baumgart M; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute., Snyder E; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute., Kluger B; Department of Neurology; and.; Division of Palliative Care, Department of Medicine, University of Rochester Medical Center, Rochester, NY., Loh KP; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute., Mendler JH; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute.
Publikováno v:
Blood advances [Blood Adv] 2021 Dec 28; Vol. 5 (24), pp. 5554-5564.
Autor:
Bawany F; University of Rochester School of Medicine and Dentistry, Rochester, NY; and., Tbakhi B; Department of Hematology and Oncology, Wilmot Cancer Center., Mendler JH; Department of Hematology and Oncology, Wilmot Cancer Center., Richardson CT; Department of Dermatology, and., Bennett JM; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY., Aljitawi OS; Department of Hematology and Oncology, Wilmot Cancer Center.
Publikováno v:
Blood advances [Blood Adv] 2020 Nov 24; Vol. 4 (22), pp. 5698-5701.
Autor:
Liesveld JL; James P. Wilmot Cancer Institute, Department of Medicine, University of Rochester, Rochester, New York, USA., Sharma N; James P. Wilmot Cancer Institute, Department of Medicine, University of Rochester, Rochester, New York, USA., Aljitawi OS; James P. Wilmot Cancer Institute, Department of Medicine, University of Rochester, Rochester, New York, USA.
Publikováno v:
Stem cells (Dayton, Ohio) [Stem Cells] 2020 Oct 01; Vol. 38 (10), pp. 1241-1253. Date of Electronic Publication: 2020 Jul 21.
Autor:
Tbakhi B; Department of Hematology, Oncology, University of Rochester, Rochester, NY., Furqan F; Department of Internal Medicine, Rochester General Hospital, Rochester, NY., Scott G; Department of Dermatology and Pathology, University of Rochester, Rochester, NY., Liesveld JL; Department of Hematology, Oncology, University of Rochester, Rochester, NY., Aljitawi OS; Department of Hematology, Oncology, University of Rochester, Rochester, NY.
Publikováno v:
EJHaem [EJHaem] 2020 Jul; Vol. 1 (1), pp. 330-333. Date of Electronic Publication: 2020 Aug 07.
Autor:
Mina A; Department of Hematology & Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA., Aljitawi OS; Division of Hematology/Oncology & Bone Marrow Transplantation Program, University of Rochester Medical Center, Rochester, NY 14642, USA.
Publikováno v:
Journal of comparative effectiveness research [J Comp Eff Res] 2020 Feb; Vol. 9 (3), pp. 149-153. Date of Electronic Publication: 2020 Jan 29.
Autor:
Abdelhakim H; Division of Hematologic Malignancies and Cellular Therapy, Internal Medicine Department, University of Kansas Medical Center, Kansas city, KS., Shune L; Division of Hematologic Malignancies and Cellular Therapy, Internal Medicine Department, University of Kansas Medical Center, Kansas city, KS., Bhatti S; Department of Internal Medicine, University of Kansas School of Medicine, Kansas City, KS., Cantilena AR; University of Kansas School of Medicine, Kansas city, KS; Cardiovascular Research Institute, University of Kansas School of Medicine, Kansas City, KS., Baran A; Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY., Lin TL; Division of Hematologic Malignancies and Cellular Therapy, Internal Medicine Department, University of Kansas Medical Center, Kansas city, KS., Ganguly S; Division of Hematologic Malignancies and Cellular Therapy, Internal Medicine Department, University of Kansas Medical Center, Kansas city, KS., Singh AK; Division of Hematologic Malignancies and Cellular Therapy, Internal Medicine Department, University of Kansas Medical Center, Kansas city, KS., Abhyankar S; Division of Hematologic Malignancies and Cellular Therapy, Internal Medicine Department, University of Kansas Medical Center, Kansas city, KS., Divine C; Division of Hematologic Malignancies and Cellular Therapy, Internal Medicine Department, University of Kansas Medical Center, Kansas city, KS., Lipe B; Division of Hematologic Malignancies and Cellular Therapy, Internal Medicine Department, University of Kansas Medical Center, Kansas city, KS., McGuirk J; Division of Hematologic Malignancies and Cellular Therapy, Internal Medicine Department, University of Kansas Medical Center, Kansas city, KS., Allin D; Emergency Department, University of Kansas Medical Center, Kansas City, KS., Aljitawi OS; Division of Hematologic Malignancies and Cellular Therapy, Internal Medicine Department, University of Kansas Medical Center, Kansas city, KS; Division of Hematology and Bone Marrow Transplantation Program, University of Rochester Medical Center, Rochester, NY. Electronic address: Omar_aljitawi@urmc.rochester.edu.
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2019 Sep; Vol. 25 (9), pp. 1713-1719. Date of Electronic Publication: 2019 Jun 03.